Rapid forecast delivery for potential late-stage pipeline acquisition
A specialty pharmaceutical company wanted to evaluate the potential of a late-stage
pipeline oral drug. The drug candidate had an attractive target product profile but was launching into a significantly genericized market.
Viscadia was asked to design and build a custom forecast model to clearly identify the risks and opportunities facing both the product and the wider market.